Trading Signals: CAPR Stock Price Prediction and Forecast (Tue. Apr. 1, 2003 - Fri. Jul. 2, 2021)(Capricor Therapeutics Inc)
| CAPR latest price $2425.0000 (7.78%) ($2250.0000 - $2425.0000) on Fri. Apr. 18, 2008. | |
| | Trend Analysis and Forecast | | | Average Daily Percentage Swing | 2.73% (three month average) | RSI | 58 | Latest Price | $2425.0000(7.78%) | Stocks Behave Similarly | Similar Stock List | Daily Trend | CAPR advances 1.5% a day on average for past five trading days. | Weekly Trend | CAPR advances 0.6% a week on average for past two weeks. | Market Behavior | Normal for large cap. Normal for small cap. | Correlated ETFs | Broad market will support CAPR advance at 0% a week (0% probability) PEJ(3%) EWI(2%) EWP(2%) IWM(2%) USO(2%) | Factors Impacting CAPR price | CAPR will decline at least -1.365% in a week (0% probabilities). EWY(-1%) XLU(0%) XLP(0%) VWO(0%) TLT(0%) | Explanation | The rally is not sustainable and not supported by the broad market. | | | | | Relative Volatility | (options are extremely cheap) | | | Market Trend Strength | -1.365% (StdDev 2.73%) | Hourly BBV | 0 () | Intraday Trend | 7.8% | | | |
|
5 Day Moving Average | $2325(4.3%) | 10 Day Moving Average | $2305.66(5.18%) | 20 Day Moving Average | $2305.04(5.2%) | To recent high | -3% | To recent low | 14.1% | Market Cap | $47.767b | | | | Capricor Therapeutics, Inc. engages in the discovery, development and commercialization of first-in-class biological therapies for the treatment of cardiac and other serious medical conditions. Its product candidate consists of CAP-1002, Cenderitide, Exosomes, CAP-1001, CU-NP and CSps. The company was founded in August 2005 and is headquartered in Beverly Hills, CA. |